concluded

Ocugen, a biopharmaceutical company focused on developing gene therapies to treat rare eye diseases, has recently announced the successful completion...

Comics have always been a beloved form of storytelling, captivating readers with their unique blend of visuals and narrative. However,...

Orient Growth Ventures, a leading venture capital firm, has successfully concluded its second fundraising round for investments in India and...

Leadership from the Front: ION and Bliss Take the Lead in LCO Split 1 2024 In the world of competitive...

Announcing the Victors of the High Times Cannabis Cup Oregon: People’s Choice Edition 2023 The High Times Cannabis Cup Oregon:...

The Potential of Cannabis as a Treatment for Covid-19, According to Researchers As the world continues to grapple with the...

EMA’s CHMP Declines Renewal of Translarna and Rejects Nezglyal and Syfovre as New Medicines The European Medicines Agency’s (EMA) Committee...

Board meeting minutes are a crucial aspect of corporate governance and play a significant role in ensuring compliance with legal...

Vitruveo, a leading platform for non-fungible token (NFT) sales and ecosystem development, has recently achieved a significant milestone by surpassing...

Astrobotic’s Peregrine lunar lander concludes mission with a dramatic fiery reentry Astrobotic, a leading space robotics company, recently made headlines...

A Guide to Clinical Investigation Timelines: MDCG Guidance Clinical investigations play a crucial role in the development and evaluation of...

Samsung, the renowned tech giant, has recently concluded its highly anticipated Unpacked 2024 event, leaving tech enthusiasts buzzing with excitement....

Announcing the Victors of the High Times Cannabis Cup Massachusetts: People’s Choice Edition 2023 The High Times Cannabis Cup Massachusetts:...

Novartis, one of the world’s leading pharmaceutical companies, recently made a decision not to pursue a partnership with Cytokinetics, a...